Address	37-24 Yuseong-daero 1628beon-gil Daejeon DE 34054 Korea, Republic Of
Employees	-
Website	http://www.peptron.co.kr
Updated	09/14/2018
Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. Its products include medicines for prostate cancer, hyperpituitarism, diabetes, degenerative neuronal disease, and obesity, peptide materials, and cosmetics. The company was founded on November 21, 1997 and is headquartered in Daejeon, South Korea.